132 related articles for article (PubMed ID: 14734126)
21. A novel polymorphism of the gene encoding furin, a TGF-beta1 activator, and the influence on cardiac allograft vasculopathy formation.
Densem CG; Mutlak AS; Pravica V; Brooks NH; Yonan N; Hutchinson IV
Transpl Immunol; 2004 Nov; 13(3):185-90. PubMed ID: 15381201
[TBL] [Abstract][Full Text] [Related]
22. Outcomes after percutaneous coronary artery revascularization procedures for cardiac allograft vasculopathy in pediatric heart transplant recipients: A multi-institutional study.
Jeewa A; Chin C; Pahl E; Atz AM; Carboni MP; Pruitt E; Naftel DC; Rodriguez R; Dipchand AI;
J Heart Lung Transplant; 2015 Sep; 34(9):1163-8. PubMed ID: 25578627
[TBL] [Abstract][Full Text] [Related]
23. Elevated uric acid levels predict allograft vasculopathy in cardiac transplant recipients.
Kittleson MM; Bead V; Fradley M; St John ME; Champion HC; Kasper EK; Russell SD; Wittstein IS; Hare JM
J Heart Lung Transplant; 2007 May; 26(5):498-503. PubMed ID: 17449420
[TBL] [Abstract][Full Text] [Related]
24. Haptoglobin phenotype 2-2 as a potentially new risk factor for spontaneous venous thromboembolism.
Vormittag R; Vukovich T; Mannhalter C; Minar E; Schönauer V; Bialonczyk C; Hirschl M; Pabinger I
Haematologica; 2005 Nov; 90(11):1557-61. PubMed ID: 16266904
[TBL] [Abstract][Full Text] [Related]
25. Influence of interleukin-10 polymorphism on the development of coronary vasculopathy following cardiac transplantation.
Densem CG; Hutchinson IV; Yonan N; Brooks NH
Transpl Immunol; 2003; 11(2):223-8. PubMed ID: 12799207
[TBL] [Abstract][Full Text] [Related]
26. Biological and clinical significance of haptoglobin polymorphism in humans.
Langlois MR; Delanghe JR
Clin Chem; 1996 Oct; 42(10):1589-600. PubMed ID: 8855140
[TBL] [Abstract][Full Text] [Related]
27. Donor haptoglobin phenotype determines outcome following liver transplantation.
Speeckaert R; Van Vlierberghe H; Troisi R; De Bacquer D; Speeckaert MM; De Buyzere ML; Claeys L; de Hemptinne B; Delanghe JR
Transpl Int; 2011 Jun; 24(6):619-26. PubMed ID: 21401731
[TBL] [Abstract][Full Text] [Related]
28. Haptoglobin 2-2 Phenotype Is Associated With Increased Acute Kidney Injury After Elective Cardiac Surgery in Patients With Diabetes Mellitus.
Feng C; Naik BI; Xin W; Ma JZ; Scalzo DC; Thammishetti S; Thiele RH; Zuo Z; Raphael J
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28982674
[TBL] [Abstract][Full Text] [Related]
29. Impaired coronary dilator responses to substance P and impaired flow-dependent dilator responses in heart transplant patients with graft vasculopathy.
Mügge A; Heublein B; Kuhn M; Nolte C; Haverich A; Warnecke J; Forssmann WG; Lichtlen PR
J Am Coll Cardiol; 1993 Jan; 21(1):163-70. PubMed ID: 7678019
[TBL] [Abstract][Full Text] [Related]
30. Layered Fibrotic Plaques Are the Predominant Component in Cardiac Allograft Vasculopathy: Systematic Findings and Risk Stratification by OCT.
Clemmensen TS; Holm NR; Eiskjær H; Løgstrup BB; Christiansen EH; Dijkstra J; Barkholt TØ; Terkelsen CJ; Maeng M; Poulsen SH
JACC Cardiovasc Imaging; 2017 Jul; 10(7):773-784. PubMed ID: 28330670
[TBL] [Abstract][Full Text] [Related]
31. Intracoronary ultrasound assessment of morphological and functional abnormalities associated with cardiac allograft vasculopathy.
Heroux AL; Silverman P; Costanzo MR; O'Sullivan EJ; Johnson MR; Liao Y; McKiernan TL; Balhan JE; Leya FS; Mullen GM
Circulation; 1994 Jan; 89(1):272-7. PubMed ID: 8281657
[TBL] [Abstract][Full Text] [Related]
32. Haptoglobin phenotypes in health and disorders.
Sadrzadeh SM; Bozorgmehr J
Am J Clin Pathol; 2004 Jun; 121 Suppl():S97-104. PubMed ID: 15298155
[TBL] [Abstract][Full Text] [Related]
33. Influence of pre-existing donor atherosclerosis on the development of cardiac allograft vasculopathy and outcomes in heart transplant recipients.
Li H; Tanaka K; Anzai H; Oeser B; Lai D; Kobashigawa JA; Tobis JM
J Am Coll Cardiol; 2006 Jun; 47(12):2470-6. PubMed ID: 16781375
[TBL] [Abstract][Full Text] [Related]
34. Association of recipient age and causes of heart transplant mortality: Implications for personalization of post-transplant management-An analysis of the International Society for Heart and Lung Transplantation Registry.
Wever-Pinzon O; Edwards LB; Taylor DO; Kfoury AG; Drakos SG; Selzman CH; Fang JC; Lund LH; Stehlik J
J Heart Lung Transplant; 2017 Apr; 36(4):407-417. PubMed ID: 27686602
[TBL] [Abstract][Full Text] [Related]
35. Efficacy of augmented immunosuppressive therapy for early vasculopathy in heart transplantation.
Lamich R; Ballester M; Martí V; Brossa V; Aymat R; Carrió I; Bernà L; Campreciós M; Puig M; Estorch M; Flotats A; Bordes R; Garcia J; Augè ; Padró JM; Caralps JM; Narula J
J Am Coll Cardiol; 1998 Aug; 32(2):413-9. PubMed ID: 9708469
[TBL] [Abstract][Full Text] [Related]
36. Interleukin-6 polymorphism: a genetic risk factor for cardiac transplant related coronary vasculopathy?
Densem CG; Ray M; Hutchinson IV; Yonan N; Brooks NH
J Heart Lung Transplant; 2005 May; 24(5):559-65. PubMed ID: 15896753
[TBL] [Abstract][Full Text] [Related]
37. Haptoglobin polymorphism and complications in established essential arterial hypertension.
Delanghe JR; Duprez DA; De Buyzere ML; Bergez BM; Callens BY; Leroux-Roels GG; Clement DL
J Hypertens; 1993 Aug; 11(8):861-7. PubMed ID: 8228210
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic accuracy of coronary angiography and risk factors for post-heart-transplant cardiac allograft vasculopathy.
Sharples LD; Jackson CH; Parameshwar J; Wallwork J; Large SR
Transplantation; 2003 Aug; 76(4):679-82. PubMed ID: 12973108
[TBL] [Abstract][Full Text] [Related]
39. Genetic polymorphism in platelet-derived growth factor and vascular endothelial growth factor are significantly associated with cardiac allograft vasculopathy.
Tambur AR; Pamboukian S; Costanzo MR; Heroux A
J Heart Lung Transplant; 2006 Jun; 25(6):690-8. PubMed ID: 16730575
[TBL] [Abstract][Full Text] [Related]
40. Associations between haptoglobin polymorphism, lipids, lipoproteins and inflammatory variables.
Braeckman L; De Bacquer D; Delanghe J; Claeys L; De Backer G
Atherosclerosis; 1999 Apr; 143(2):383-8. PubMed ID: 10217368
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
